Key result
Carotid artery stenting with the Vascuflex SEC stent significantly reduced diameter stenosis from 84.1% to 9.1% (p<0.001) and demonstrated a low 30-day neurological complication rate of 4%.
Observational (n=50)
No
Absolute Event Rate: 9.1% vs 84.1%
p-value: p=<0.001
Carotid artery stenting with the Vascuflex SEC stent and morphology-guided embolic protection is safe and effective, achieving 100% procedural success with a low complication rate at 30 days.
Supports feasibility in carotid stenting cohorts; leaves open confirmation via randomized trials before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pieniążek et al. (2011) conducted an observational in Carotid artery stenosis (n=50). Vascuflex SEC stent was evaluated on Diameter stenosis (p=<0.001). Carotid artery stenting with the Vascuflex SEC stent significantly reduced diameter stenosis from 84.1% to 9.1% (p<0.001) and demonstrated a low 30-day neurological complication rate of 4%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: